no statement of use filed
on 06 Dec 2021
Last Applicant/ Owned by
215 First Street
Cambridge
MA
02142
Serial Number
88895910 filed on 30th Apr 2020
Registration Number
N/A
Filing Basis
1. intent to use
2. intent to use current
Disclaimer
NO DATA
Pharmaceutical preparations for the treatment of neuromuscular diseases and disorders, muscular dystrophies, central nervous system diseases and disorders, genetic diseases and disorders; Pharmaceutical preparations based on morpholino oligomer technology platform for the treatment of neuromuscular diseases and disorders, muscular dystrophies, central nervous system diseases and disorders, geneticRead More
Pharmaceutical preparations for the treatment of neuromuscular diseases and disorders, muscular dystrophies, central nervous system diseases and disorders, genetic diseases and disorders; Pharmaceutical preparations based on morpholino oligomer technology platform for the treatment of neuromuscular diseases and disorders, muscular dystrophies, central nervous system diseases and disorders, genetic diseases and disorders, and for the regulation of protein production; Pharmaceutical preparations that modulate RNA expression for the treatment of neuromuscular diseases and disorders, muscular dystrophies, central nervous system diseases and disorders, genetic diseases and disorders, and for the regulation of protein production; Gene therapy products, namely, gene delivery pharmaceuticals; Pharmaceutical preparations for gene therapy, gene editing, and genome editing; Gene therapies for the treatment of neuromuscular diseases and disorders, muscular dystrophies, central nervous system diseases and disorders, genetic diseases and disorders; Biological preparations for the treatment of neuromuscular diseases and disorders, muscular dystrophies, central nervous system diseases and disorders, genetic diseases and disorders; Viruses, viral vectors and viral constructs for the treatment of neuromuscular diseases and disorders, muscular dystrophies, central nervous system diseases and disorders, genetic diseases and disorders; Pharmaceutical preparations, biological preparations and gene therapy products in the nature of pharmaceutical and biological preparations for the treatment of genetic disorders and diseases
No 88895910
No Service/Collective Mark
No
No
No
No
No
No
No
No
No
| Status Date | Action Taken |
|---|---|
| 06th Dec 2021 | ABANDONMENT - NO USE STATEMENT FILED |
| 06th Dec 2021 | ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILED |
| 17th Mar 2021 | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED |
| 15th Mar 2021 | EXTENSION 1 GRANTED |
| 15th Mar 2021 | TEAS EXTENSION RECEIVED |
| 15th Mar 2021 | EXTENSION 1 FILED |
| 03rd Nov 2020 | NOA E-MAILED - SOU REQUIRED FROM APPLICANT |
| 08th Sep 2020 | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED |
| 08th Sep 2020 | PUBLISHED FOR OPPOSITION |
| 19th Aug 2020 | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED |
